Back to Search
JESSICA COPLAND, MD
MD
Family Medicine Physician
NPI: 1083743546IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 2005
Research & Publications (20)
Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?
PMID 19382224·Bioessays·2009
6-review
Molecular diagnosis of a BRAF papillary thyroid carcinoma with multiple chromosome abnormalities and rare adrenal and hypothalamic metastases.
PMID 17199440·Thyroid·2006
5-case
Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1.
PMID 16331265·Oncogene·2006
7-preclinical
Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
PMID 12970754·Oncogene·2003
8-other
The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside.
PMID 12795413·Recent Prog Horm Res·2003
6-review
Oxytocin receptor regulation and action in a human granulosa-lutein cell line.
PMID 11967182·Biol Reprod·2002
8-other
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.
PMID 19118035·Clin Cancer Res·2009
8-other
C-lysine conjugates: pH-controlled light-activated reagents for efficient double-stranded DNA cleavage with implications for cancer therapy.
PMID 19637922·J Am Chem Soc·2009
8-other
FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases.
PMID 19564415·Mol Cell Biol·2009
7-preclinical
Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth.
PMID 19208833·Cancer Res·2009
7-preclinical
Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells.
PMID 19072129·Nano Lett·2009
7-preclinical
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.
PMID 18987168·Endocr Relat Cancer·2009
6-review
Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein.
PMID 18294846·Bioorg Med Chem Lett·2008
8-other
Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway.
PMID 18794080·Clin Cancer Res·2008
7-preclinical
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.
PMID 18713817·J Clin Endocrinol Metab·2008
8-other
ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice.
PMID 18583996·Cancer Gene Ther·2008
4-observational
A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease.
PMID 18407999·J Biol Chem·2008
8-other
Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.
PMID 18299279·Carcinogenesis·2008
8-other
p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression.
PMID 19015320·J Cell Biol·2008
7-preclinical
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.
PMID 17699851·Clin Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5516 CENTRAL AVE
CHARLOTTE, NC 28212 - Phone
- (704) 446-7700
Quick Facts
- NPI
- 1083743546
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile